Safety and Efficacy of MultiHance in Pediatric Patients
Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the safety and enhancing properties of the magnetic
resonance imaging (MRI) contrast agent MultiHance in children aged 2 to 17 years having
central nervous system (CNS) disorders.